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Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas
Adaptation Determined Using a Biofilm Enrichment Assay
Gary E. Heussler, Jon L. Miller, Courtney E. Price, Alan J. Collins, George A. O’Toole
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA
ABSTRACT
CRISPR (clustered regularly interspaced short palindromic repeat)-Cas (CRISPR-associated protein) systems are diverse and
found in many archaea and bacteria. These systems have mainly been characterized as adaptive immune systems able to protect
against invading mobile genetic elements, including viruses. The first step in this protection is acquisition of spacer sequences
from the invader DNA and incorporation of those sequences into the CRISPR array, termed CRISPR adaptation. Progress in
understanding the mechanisms and requirements of CRISPR adaptation has largely been accomplished using overexpression of
cas genes or plasmid loss assays; little work has focused on endogenous CRISPR-acquired immunity from viral predation. Here,
we developed a new biofilm-based assay system to enrich for Pseudomonas aeruginosa strains with new spacer acquisition. We
used this assay to demonstrate that P. aeruginosa rapidly acquires spacers protective against DMS3vir, an engineered lytic vari-
ant of the Mu-like bacteriophage DMS3, through primed CRISPR adaptation from spacers present in the native CRISPR2 array.
We found that for the P. aeruginosa type I-F system, the cas1 gene is required for CRISPR adaptation, recG contributes to (but is
not required for) primed CRISPR adaptation, recD is dispensable for primed CRISPR adaptation, and finally, the ability of a pu-
tative priming spacer to prime can vary considerably depending on the specific sequences of the spacer.
IMPORTANCE
Our understanding of CRISPR adaptation has expanded largely through experiments in type I CRISPR systems using plasmid
loss assays, mutants of Escherichia coli, or cas1-cas2 overexpression systems, but there has been little focus on studying the adap-
tation of endogenous systems protecting against a lytic bacteriophage. Here we describe a biofilm system that allows P. aerugi-
nosa to rapidly gain spacers protective against a lytic bacteriophage. This approach has allowed us to probe the requirements for
CRISPR adaptation in the endogenous type I-F system of P. aeruginosa. Our data suggest that CRISPR-acquired immunity in a
biofilmmay be one reason that many P. aeruginosa strains maintain a CRISPR-Cas system.
CRISPR (clustered regularly interspaced short palindromic re-peat)-Cas (CRISPR-associated protein) systems are diverse,
widespread, and currently classified into six different types (1, 2)
and are found in over 84% and 45% of sequenced archaeal and
bacterial genomes, respectively (3). The general function of a
CRISPR-Cas system is to provide adaptive immunity against mo-
bile genetic elements (MGEs), including viruses and plasmids (4–
6). This CRISPR-mediated immunity is generated through three
stages. In the first stage, termed CRISPR adaptation, a small sec-
tion of invadingMGEnucleic acid (usually 30 to 40 bp, termed the
protospacer) is incorporated into the CRISPR array as a spacer
along with an additional CRISPR repeat. In the second step,
CRISPR RNA (crRNA) generation, the CRISPR array is tran-
scribed into long, noncoding RNA and subsequently processed
into individual spacers which associate withCas proteins, forming
the crRNA ribonucleoprotein complex. The final step is CRISPR
interference, in which the spacer region of the crRNA binds in-
vadingMGEs at a complementary site throughWatson-Crick base
pairing and recruits a Cas nuclease to degrade the bound target
(for a recent review, see reference 7).
Our understanding of CRISPR adaptation has greatly in-
creased in the last several years but still lags behind advances in
understanding crRNA generation and CRISPR interference.Most
CRISPR adaptation research in the type I system focuses on the
Escherichia coli type I-E system, but since this CRISPR-Cas system
is naturally H-NS silenced, CRISPR adaptation studies have relied
on either overexpression of Cas1 and Cas2 in the absence of
CRISPR interference (8) or the use of ahns strain of E. coli (9). E.
coli has also been used to investigate adaptation in the type I-F
system through expression of a heterologous type I-F system from
Pseudomonas aeruginosa in E. coli (10). These studies have been
instrumental in advancing our understanding of the mechanisms
and genetic requirements for adaptation, but the approaches used
limit our understanding of the role of the CRISPR-Cas system in
its native context. The endogenous CRISPR-Cas system of P.
aeruginosa and its importance during challenge with DMS3vir
have been studied previously (11, 12), andwe aim to expand upon
these types of experiments by studying the role of theP. aeruginosa
CRISPR-Cas system in biofilm growth.
Pseudomonas aeruginosa strain UCBPP-PA14 (here abbrevi-
ated P. aeruginosa PA14) contains a type I-F CRISPR-Cas system
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organized such that the canonical type I-F cas genes are flanked by
two CRISPR arrays, termed CRISPR1 and CRISPR2, containing
13 and 21 spacers, respectively (Fig. 1) (13).Our lab has previously
shown that this CRISPR-Cas system is active under normal labo-
ratory growth conditions (14) and capable of acquiring protective
spacers during challenge with the bacteriophage DMS3vir, a lytic-
only variant of the bacteriophage DMS3 (15). However, even
though the native CRISPR2 locus contains 3 putative DMS3-tar-
geting priming spacers (spacers whose sequences partially match
the phage target sequence and increase the likelihood of incorpo-
ration of new spacers against the phage), after phage infection and
isolation of resistant strains, less than 1%of these resistant isolates
had acquired new spacers, while the vast majority (99%) had
gained resistance throughmutation of the type IV pilus (T4P), the
known receptor of DMS3vir (16) as well asmany other Pseudomo-
nas phages (17). Thus, while coinoculation of P. aeruginosa with
DMS3vir in a culture tube results in spacer acquisition, this event
is too inefficient to be used as a means of investigating natural
CRISPR adaptation in P. aeruginosa, necessitating a strategy for
increasing the frequency of native spacer acquisition.
Given that the T4P is known to play an important role in bio-
film formation in P. aeruginosa (18), we hypothesized that cells
grown in a biofilm during phage challenge would be less likely to
gain resistance to DMS3vir through mutations of T4P. We show
here that a biofilm-based enrichment system greatly increases the
ability to detect CRISPR adaptation events, allowing us to inves-
tigate the efficiency of different priming spacers, protospacer se-
quences, and the genetic requirements of theP. aeruginosa type I-F
system in the context of viral immunity. Furthermore, CRISPR-
Cas systems are widespread in P. aeruginosa strains (19, 20); thus,
a better understanding of the role of the P. aeruginosa type I-F
CRISPR-Cas system in the context of biofilm growth may help
explain the prevalence of these systems.
MATERIALS AND METHODS
Strains and media. The strains, plasmids, and primers used in this study
are listed in Table S1 in the supplemental material. P. aeruginosa strain
PA14 was used in this study. P. aeruginosa and E. coli strains were rou-
tinely cultured in lysogeny broth (LB) at 37°C. The growth media were
supplemented with gentamicin (Gm) at the following concentrations:
10 g ml1 for E. coli and 50 g ml1 for P. aeruginosa. The recD,
recG, CRISPR1CRISPR2sp1-19, CRISPR1CRISPR2sp1-19 
sp20-5MM, and CRISPR2-minimum strains and deletion plasmids were
generated using allelic exchange and Saccharomyces cerevisiae recom-
bineering techniques described previously (21). The recG::TnM strain
used here is from the P. aeruginosa PA14 nonredundant library (22), and
the transposon insertion was confirmed via PCR.
Biofilm enrichment assay. The indicated P. aeruginosa strains were
grown overnight and standardized to an optical density at 600 nm of 3.0,
and then 100 l of the culture (2.5  108 CFU) was added to 5 ml of
M63minimalmedium supplementedwith 0.4% arginine and 1mMmag-
nesium sulfate (a biofilm-inducing medium) per well in a 6-well tissue
culture dish. The P. aeruginosa strains indicated below were coinoculated
with 2.5  106 PFU of the DMS3vir phage in each well (multiplicity of
infection, 0.01) and grown overnight at 37°C. After incubation, the me-
dium was aspirated and the wells were washed once with 5 ml of phos-
phate-buffered saline (PBS), removing any planktonic bacteria and leav-
ing behind only the biofilm population. The biofilm population was
isolated by using a 25-cm Sarstedt cell scraper to remove any attached
bacterial cells at the air-liquid interface, and the cells were subsequently
collected in 1 ml of PBS. These cells were then washed with 1 ml PBS and
resuspended in 50l of PBS, and the entire 50l was inoculated into 5ml
LB and grown for either 10 h (for the slow-growingrecDmutant) or 6 h
(for all other strains) at 37°C. After the biofilm was allowed to form, the
cells were exposed to fresh DMS3vir at concentrations and under condi-
tions exactly the same as those described above. After coincubation of the
biofilm cells and phage, the remaining biofilms cells were collected as
described above. Additionally, an aliquot of the planktonic population
from the wild-type (WT) P. aeruginosa plus DMS3vir condition was col-
lected prior to aspiration. Both planktonic and biofilm cells were serially
diluted, plated on LB agar, and incubated at 37°C for 16 h to yield single
colonies. For each condition, at least 200 single colonies were repatched
onto LB agar using a sterile pipette tip and grown for 16 h at 37°C to assess
their twitching phenotype, as describe in the next section.
Twitch assay.The twitch assay was performed as described previously
(23). Briefly, a sample from repatched isolates not displaying any bacte-
riophage-mediated lysis (as judged by a lack of obvious plaques) was col-
lected using a sterile pipette tip, punctured through LB agar, and depos-
ited onto the hard plastic of the petri plate. The samples were then allowed
to grow for 36 h at 37°C, at which point the LB agar was carefully peeled
away. The bacteria were visualizedwith the addition of 0.1% crystal violet.
Twitch-positive strains move along the plastic away from the inoculation
point, while twitch-negative cells remain at the inoculation point.
Detecting newly acquired spacers. Any repatched isolates from the
biofilm-based spacer enrichment assay not showing signs of bacterio-
phage-mediated lysis and displaying a twitch-positive phenotype were
used as a template for PCR, using primers amplifying the leader end of
either the CRISPR1 or CRISPR2 array. For the isolates indicated below,
one of the same primers was used for Sanger sequencing to characterize
the newly acquired spacers.
Statistical analysis. The data presented in Fig. 3 were analyzed using
GraphPad Prism (version 5) software. The data represent the means 	
standard deviations from three independent experiments with multiple
replicates. All data were treated as normally distributed, and comparisons
were tested with Student’s t test.
RESULTS
P. aeruginosa rapidly gains resistance to the lytic bacteriophage
DMS3vir under biofilm-inducing conditions. The biofilm en-
richment system involves two consecutive incubations of P.
aeruginosa and DMS3vir under biofilm-inducing conditions. All
FIG 1 Cartoon of the type I-F CRISPR-Cas system in Pseudomonas aeruginosa strain UCBPP-PA14. Gene names and spacers numbers are indicated and
described in the text.
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the bacterial cells used to inoculate the medium for the second
biofilm incubation were isolated from the biofilm formed at the
end of the first incubation. Because the biofilm cells are exposed to
phage DMS3vir, this approach strongly enriches for isolates that
efficiently form biofilms and that are resistant to DMS3vir infec-
tion. The enrichment procedure is outlined in Fig. 2.
To assess the impact of phage infection on theWT strain and a
strain lacking the CRISPR-Cas region, 2.5 108 CFU of either P.
aeruginosaorP. aeruginosa inwhich the entireCRISPR-Cas region
was deleted (CR) was added either alone or with 2.5 106 PFU
of DMS3vir to 5 ml of biofilm-inducing minimal medium in a
6-well plate. After 24 h of static growth at 37°C, both the biofilm
and planktonic populations were isolated and aliquots from each
population were serially diluted and plated to measure the
amount of viable bacteria (the number of CFU). As illustrated in
Fig. 3, DMS3vir infection significantly reduced the levels of both
WTandCRP. aeruginosa cells in the planktonic population (Fig.
3A) as well as the biofilm population (Fig. 3C) after 24 h of incu-
bation. The planktonic population of WT and CR cells grown
with DMS3vir had, on average, 91% and 85% fewer cells, respec-
tively, than the planktonic population ofWTandCR cells grown
without DMS3vir (Fig. 3A). Similarly, the biofilm population of
WT andCR cells grownwithDMS3vir had, on average, 90% and
97% fewer cells, respectively, than the biofilm population grown
without DMS3vir (Fig. 3C).
The biofilm cells isolated after the first incubation step were
subsequently grown planktonically for 6 h in LB at 37°C to gener-
ate enough cells to inoculate the second biofilm assay plates re-
quired for our enrichment protocol. After the 6 h of planktonic
growth, the WT and CR cells were added to 5 ml of a biofilm-
inducing minimal medium either with or without fresh DMS3vir
at the same counts used in the assay described above. After 24 h of
growth at 37°C, both the biofilm and planktonic populations were
again isolated, and aliquots were serially diluted and plated to
measure the number of CFU. In contrast to the results from the
first round of incubation (Fig. 3A and C), there was no significant
decrease in the number of either WT or CR cells incubated with
DMS3vir compared to the number of cells grown in the absence of
the bacteriophage in the planktonic population (Fig. 3B), indicat-
ing that both theWT andCR planktonic cells had become resis-
tant to DMS3vir-mediated lysis. Interestingly, while the biofilm
population ofWT cells grown with DMS3virwas not significantly
different from the biofilmpopulation ofWTcells grown alone, the
biofilm population of CR cells grown with DMS3vir had, on
average, 79% fewer cells than the population of CR cells grown
alone, a significant (P 
 0.05) decrease (Fig. 3D). It should be
noted that while the difference between the WT biofilm and WT
plus DMS3vir biofilm population was not significant, there were
still, on average, 40% fewer cells in the WT plus DMS3vir popu-
lation, and the variability of the assay may partially contribute to
the lack of significance measured by Student’s t test. Nevertheless,
these data indicate that both WT and CR P. aeruginosa can rap-
idly gain resistance to DMS3vir during biofilm growth and that
the P. aeruginosa cells with a functional CRISPR-Cas system had a
slight but reproducible advantage over CRISPR-deficient P.
aeruginosa cells when growing in a biofilm in the presence of a lytic
phage.
Pseudomonas aeruginosa incorporates spacers protective
against lytic bacteriophage DMS3vir under biofilm-inducing
conditions. The biofilm-specific increase of WT versus CR P.
aeruginosa cells when cells were grown in the presence of DMS3vir
suggested that theWT cells gained resistance to DMS3vir through
spacer acquisition, in addition to or perhaps in preference to
through T4Pmutations, especially given that T4Pmutations neg-
atively impact the ability of P. aeruginosa to form a biofilm. To test
this idea, after isolation and serial dilution plating of the biofilm
population from the second biofilm incubation step (Fig. 2), at
least 200 colonies for each condition were repatched onto LB agar
in three separate assays. Not all cells in the biofilm gained resis-
tance to DMS3vir, and to eliminate nonresistant cells, any isolate
that showed signs of lysis from DMS3vir particles that had been
retained from the infection step were eliminated from further
FIG2 Schematic of biofilm enrichment assay. Pseudomonas aeruginosa andDMS3virwere coinoculated at amultiplicity of infection of 0.01 using 2.5 108 CFU
and 2.5 106 PFU of P. aeruginosa and DMS3vir, respectively, during each of the two biofilm incubations.
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analysis (Fig. 2; compare nonresistant [NR] versus resistant [R]
patches). All the remaining isolates were then assayed for twitch-
ing motility, as described previously (24) and as shown in Fig. 2.
Isolates that had gained DMS3vir resistance through a T4P muta-
tion were easily distinguishable due to their lack of twitching, and
any isolate that was twitch positive was presumed to have acquired
a new spacer that blocked infection and thus was screened for
spacer acquisition using primers that amplify the leader-proximal
ends of both CRISPR1 and CRISPR2.
Unlike the low rate (1%) of spacer acquisition previously
observed during P. aeruginosa and DMS3vir coincubation (15),
on average, 37.7% of the DMS3vir-resistant isolates of the WT
strain had acquired new spacers, while the remaining 62.3% had
gained resistance through the T4P mutation (Fig. 4A). The bio-
film-resistant population of the CR mutant strain was 100%
twitch negative in these experiments, suggesting that no other
means of resistance besides a mutation in the T4P apparatus was
acquired.
Cas1 is required for new spacer acquisition. Cas1 is univer-
sally conserved across CRISPR-Cas systems and has been shown
to be required for CRISPR adaptation (8, 25), including for a
heterologous P. aeruginosa type I-F system overexpressed in E. coli
(10) and for the endogenous type I-F system of Pectobacterium
atrosepticum during CRISPR adaptation against plasmids (26). To
test the requirement for endogenous Cas1 in CRISPR adaptation
by P. aeruginosa versus a lytic phage, a cas1 mutant was assayed
for spacer acquisition using the biofilm enrichment system. Sim-
ilar to the CRISPR-deficient CR mutant, all of the resistant iso-
lates after the second biofilm incubation had lost T4P functional-
ity (Fig. 4A), confirming that the cas1 gene is required for CRISPR
adaptation by P. aeruginosa challenged with lytic bacteriophage.
Biofilm growth enhances spacer acquisition. The underlying
premise of our assay is that growth in a biofilm should enhance the
frequency of spacer acquisition by selection for the subpopulation
of cells with functional T4P, a cell appendage required for robust
biofilm formation (18). It has been shown previously that P.
aeruginosa more likely gains resistance to DMS3vir through
CRISPR adaptation rather than through mutations in genes en-
coding T4P during coincubation in a minimal medium (11).
Therefore, to determine if the CRISPR adaptation frequency of
38% observed in WT P. aeruginosa is specifically the result of
biofilm growth andnot simply growth in aminimalmedium (pre-
vious assays were performed in rich LB medium), the planktonic
population of WT P. aeruginosa incubated with DMS3vir isolated
after the second incubation step was assayed for CRISPR adapta-
tion in the same manner as the biofilm population in three sepa-
rate experiments. Of the resistant planktonic cells, on average,
20.3% had gained resistance through CRISPR adaptation, with
the remaining 79.7% gaining resistance through T4P mutations
(Fig. 4A), significantly less (P 0.01) than theCRISPR adaptation
frequency (37.7%) observed in the resistant biofilm population
FIG 3 Number of viable P. aeruginosa cells in the planktonic and biofilm populations after the biofilm enrichment assay. After both the first (A) and second (B)
24-h challenge in biofilm-inducing medium, 1 ml of the planktonic culture was collected, serially diluted, and plated to measure the number of CFU. Addition-
ally, after both the first (C) and second (D) 24-h challenge in biofilm-inducing medium, the total biofilm population at the air-liquid interface in each well was
isolated using a cell scraper, washed, resuspended in PBS, serially diluted, and plated to measure the number of CFU. Error bars represent standard deviations
from three replicates. *, significant difference (P 
 0.05, Student’s t test) of the specified condition from the equivalent condition without DMS3vir; ns, no
significant difference.
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(see Table S2 in the supplementalmaterial for the raw data used in
the statistical analysis).
Since the level of spacer acquisition in the planktonic popula-
tion was higher than what was previously observed after coinocu-
lating P. aeruginosa with DMS3vir in LB medium overnight at
37°C with shaking (15), the culture tube-based P. aeruginosa and
DMS3vir coincubation was repeated using WT and CR P.
aeruginosa isolates in LB medium to confirm the low adaptation
frequency observed previously. Of the 300 resistant isolates,
2.3% of the WT P. aeruginosa isolates and 0% of the CR isolates
had gained resistance through CRISPR adaptation, with the re-
maining isolates gaining resistance through T4P mutation (Fig.
4B), confirming the low frequency of spacer acquisition in rich
medium for planktonically growing bacteria.
Taken together, these data suggest that P. aeruginosa isolates
grown planktonically and challenged with DMS3vir acquire resis-
tance to DMS3vir via CRISPR adaptation at a much higher rate
(20% versus 2%) when grown in a minimal medium with static
growth thanwhen grown in a richmediumwith shaking. Further-
more, the highest rate of CRISPR adaptation to DMS3vir (38%)
was observed in the biofilmpopulation of cells grown in aminimal
medium, supporting our strategy for increasing the rate of spacer
acquisition in P. aeruginosa by enriching for cells with a functional
T4P during challenge with DMS3vir.
Multiple spacers are preferentially incorporated with a bi-
ased incorporation into the CRISPR2 array.Of the P. aeruginosa
isolates that incorporated new spacers providing resistance to
DMS3vir, 100were randomly selected to assay the specific number
of spacers acquired and to determine intowhichCRISPR array the
spacers were inserted. A strong bias for multiple CRISPR inser-
tions was observed in our system, with only 27 out of 100 isolates
inserting a single spacer (Fig. 4C). These data are similar to obser-
vations in the type I-F system of P. atrosepticum; during CRISPR
adaptation against a transformed plasmid, only 24% (9/37) of
plasmid-insensitive strains inserted a single spacer (27), suggest-
ing similarities inCRISPR adaptation against a plasmid and versus
a lytic bacteriophage in the type I-F system.Multiple incorporated
spacers are likely important since it has been shown in P. aerugi-
nosa that spacer diversity against DMS3vir is beneficial to the sur-
vival of the bacteria (12).
Additionally, of the 100 resistant isolates, 76 inserted new spac-
ers into only CRISPR2, 5 inserted new spacers into only CRISPR1,
and 19 inserted new spacers into both CRISPR1 and CRISPR2
(Fig. 4D), demonstrating that CRISPR2 and CRISPR1 are both
FIG 4 Resistance to DMS3vir in the biofilm enrichment assay is gained through either type IV pilus loss of function or Cas1-dependent spacer acquisition. After
the second biofilm incubation in the biofilm enrichment assay, both the biofilm population and the planktonic population of P. aeruginosawere plated for single
colonies. At least 200 colonies under each specified condition from at least two replicates were repatched on LB agar. (A) Isolates that were resistant to DMS3vir
and twitch negative were scored as a type IV pilus (T4P) mutant, while isolates that were resistant to DMS3vir, that were twitch positive, and that demonstrated
spacer acquisition, as determined by PCR of the CRISPR arrays, were scored as spacer acquisition positive. Type IV pilus mutant and spacer acquisition-positive
isolates are displayed under each condition as a percentage of the totalDMS3vir resistant population under that condition. (B)After 24 h of coincubation of either
WT or CRISPR-deficient (CR) P. aeruginosa isolates with DMS3vir at a multiplicity of infection of 0.01 at 37°C in 5 ml of LB, 200 single colonies from two
replicates under each condition were isolated, scored, and displayed as described in the legend to panel A. (C and D) One hundred randomly selected
spacer acquisition-positive isolates from theWT and DMS3vir coincubation conditions in the biofilm enrichment assay were scored for insertion of either
a single spacer or multiple spacers (C) and insertion of a new spacer into the CRISPR1, CRISPR2, or both CRISPR1 and CRISPR2 arrays (D), as
determined by PCR.
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functional in CRISPR interference, although there appears to be a
bias for inserting new spacers into CRISPR2 in these experiments,
similar to what had previously been observed in P. aeruginosa
(11). These data are also similar to observations in the type I-F
system of P. atrosepticum; of 105 new spacers inserted into three
CRISPR arrays in P. atrosepticum, 65%, 32%, and 
3% were
found in CRISPR1, CRISPR2, and CRISPR3, respectively (27),
further suggesting common themes of the type I-F system regard-
less of target (plasmid versus lytic bacteriophage) or host (P. atro-
septicum versus P. aeruginosa).
Spacers incorporated using the biofilm enrichment system
are the result of primed CRISPR adaptation. Recent studies of
the type I-E CRISPR-Cas system of E. coli separate type I CRISPR
adaptation into two distinct types. In the first type, termed naive
adaptation, new spacers are incorporated into a CRISPR array in
the absence of CRISPR interference components. This naive ad-
aptation was demonstrated via the overexpression of the cas1 and
cas2 genes (8, 28). In the second type of adaptation, termed
primed adaptation, a nucleic acid target is bound by a crRNA
ribonucleoprotein complex that cannot engage in CRISPR inter-
ference due to mismatches between the protospacer and the
spacer or a nonconsensus protospacer adjacent motif (PAM), but
the presence of this mismatched spacer results in rapid and effi-
cient spacer acquisition from regions proximal to the priming
protospacer (25, 29).
P. aeruginosa contains three spacers in the native CRISPR2
array that can potentially participate in primed adaptation against
bacteriophage DMS3, as illustrated in Fig. 5. The first, CRISPR2
spacer 20 (CR2_sp20), is 100% complementary to DMS3 but can-
not interfere due to a nonconsensus PAM (AG instead of GG).
The second, CR2_sp17, is partially complementary to DMS3 with
5 mismatches, including 4 in the seed region, and, in addition,
targets a protospacer with a nonconsensus PAM (GA instead of
GG). It should be noted that the mismatches between CR2_sp17
and DMS3 likely exist because of a single nucleotide deletion on
the phage genome; if a thymine is added where the identity be-
tween the spacer and target ends, CR2_sp17 would have a 100%
match with the correct PAM. The third, CR2_sp1, is partially
complementary to DMS3 with 5 mismatches, but the target has a
consensus PAM. Notably, binding of CR2_sp1 to the DMS3 pro-
tospacer inserted on the P. aeruginosa chromosome is responsible
for the CRISPR-dependent modification of biofilm formation re-
ported previously by our group (14).
To assay if the CRISPR adaptation observed in the biofilm
enrichment system is the result of primed adaptation or naive
adaptation, a mutant was generated in which the CRISPR1 array
was deleted and all spacers in the CRISPR2 array were deleted,
leaving only a single repeat and the leader sequence (see Fig. S1 in
the supplemental material), since a single repeat and leader se-
quence has been shown to be sufficient for naive adaptation in the
E. coli type I-E system (8). Therefore, any newly acquired spacer in
this mutant background would be the result of naive adaptation.
This construct, termed CRISPR-minimum, was then analyzed via
the biofilm enrichment assay. To increase the likelihood of detec-
tion of an acquired spacer, the assay was modified slightly in that
rather than repatching the colonies (step 6 in Fig. 2), the bacteria
were plated on freshly poured LB agar (therefore, the plates had a
higher moisture level than typical plates) so that any twitching-
positive colony developed a distinct rough appearance, as previ-
ously reported (15), and could therefore be easily identified.While
this modification of the assay prevents the determination of the
rates of T4P mutations in resistant isolates, since DMS3vir-resis-
tant isolates are indistinguishable from non-DMS3vir-resistant
isolates and not every twitch-positive colony displays the rough
appearance, it allows the rapid screening of a large number of
isolates for putative spacer acquisition events. Over 10,000 colo-
nies were screened, and 768 rough colonies were assayed for
spacer acquisition by PCR, with no new spacers being detected.
Therefore, since no naive adaptation was detected, our data sug-
gest that primed adaptation is the predominant mode of spacer
acquisition in the P. aeruginosa type I-F CRISPR-Cas system.
To determine which of the three putative priming spacers il-
lustrated in Fig. 5 contribute to primed adaptation, the CRISPR
arrays of 35 of the CRISPR-positive resistant bacteria isolated
from the biofilm enrichment system were sequenced, resulting in
the characterization of 87 new spacers (see Table S3 in the supple-
mental material). Of the 87 spacers examined, the vast majority
(84/87) were likely primed by CR2_sp1, on the basis of their dis-
tribution around the CR2_sp1 DMS3 target (see Table S3). This
finding is similar to that of previous work, in which the vast ma-
jority of newly acquired spacers in resistant P. aeruginosa isolates
after coincubation with DMS3vir were likely primed by CR2_sp1
(11). Previously, when the P. aeruginosa type I-F CRISPR-Cas
system was overexpressed in E. coli, newly acquired primed spac-
ers targeting regions up to 5,000 bp from the location of the prim-
ing protospacer were detected (10). In our system, putative
primed spacers targeting regions up to 6,000 bp away from the
CR2_sp1 target were detected, suggesting that the long range of
type I-F CRISPR priming observed previously in E. coli is not due
to an artifact of heterologous expression. Additionally, of these 84
CR2_sp1-primed spacers, only 4 targeted a region of DMS3with a
nonconsensus PAM (GC, AG, TG, and GC in spacer numbers 11,
FIG 5 The three putative priming spacers located in the native CRISPR2
locus of P. aeruginosa strain UCBPP-PA14 (top sequences) along with their
cognate DMS3 target (bottom sequences). The PAM position is under-
lined, and the DMS3 location listed indicates the position of the 32-bp
protospacer in the DMS3 genome.
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27, 33, and 69, respectively), with three of these spacers (spacers
11, 27, and 33) targeting a region of DMS3 with a consensus PAM
shifted 1 nucleotide away (i.e., GG in the1/1 or2/3 posi-
tion instead of the canonical1/2 position), an occurrence ob-
served in other type I CRISPR systems and termed “PAM slip-
page” (27, 30).
The remaining 3 spacers that we identified from this collection
of 87 spacers were potentially primed by spacer CR2_sp20. The
first two of these spacers target DMS3 within 250 bp of the
CR2_sp20 target, and the third spacer targets DMS3 within 3,000
bp (see Table S3 in the supplemental material). All three of these
putative CR2_sp20-primed spacers were found in the same iso-
late, strongly suggesting that spacer incorporation likely occurred
only once in these resistant isolates, with the number of insertions
being dependent on howmany new spacers were acquired during
a single priming event, in line with themodel proposed in the type
I-F system of P. atrosepticum (27).
Spacer acquisition occurs in a biased manner in the biofilm
enrichment assay. A key difference between type I-E- and type
I-F-primed spacer acquisition is the biases observed during pro-
tospacer selection. It was shown in the type I-E CRISPR-Cas sys-
tem of E. coli that during CRISPR priming, new spacers that target
the same strand targeted by the priming spacer are incorporated
(9, 25). Conversely, in type I-F CRISPR priming, it was demon-
strated that acquired spacers show no bias in respect to the tar-
geted versus nontargeted strand but, instead, that new spacers
preferentially target sites 5= of the priming spacer target on either
the targeted or the nontargeted strand (10, 11, 27); the same bias
has also been reported in the type I-B system (31).
Of the 83CR2_sp1 putatively primed spacers that target DMS3
within 6,000 bp of the CR2_sp1 target, protospacer selection was
similar to that in other type I-F systems. There was minimal bias
between the target strand and the nontarget strand, with 53% of
new spacers targeting the same strand as CR2_sp1 and 46% tar-
geting the opposite strand (Fig. 6). However, there was an ob-
served bias between protospacers selected in the 3= or 5= direction
relative to the CR2_sp1 target, with 73% of new spacers targeting
a protospacer present in the 5= direction relative to the CR2_sp1
target and only 27% targeting a protospacer in the 3= direction of
the CR2_sp1 target (Fig. 6). These data are similar to what has
previously been shown with endogenous type I-F CRISPR adap-
tation against a lytic bacteriophage (11) and confirm that the pro-
tospacer selection biases previously observed reflect a general
property of the type I-F system.
RecD is dispensable for primed acquisition in the P. aerugi-
nosa type I-F CRISPR-Cas system, while RecG contributes to
efficient priming. Recent work has demonstrated the involve-
ment of both the RecBCD complex and the RecG protein in naive
and primed CRISPR adaptation, respectively (28, 32). The
RecBCD complex is required for naive adaptation in the type I-E
system of E. coli and likely contributes to adaptation through sin-
gle-stranded DNA generation at double-stranded breaks, such as
those encountered during replication, thereby providing a sub-
strate for Cas1 (28). Regarding primed adaptation, in the E. coli
type I-E system, RecG and PriA were shown to be required for
primed adaptation, presumably through R-loop removal after
crRNA binding, allowing the Cas1-Cas2 complex access to the
single-stranded DNA generated by Cas3 (32). We tested if these
proteins were playing a similar role in the type I-F system of P.
aeruginosa using the biofilm enrichment system and hypothesized
that since all spacer acquisition in our system is likely primed,
deletion of the recD gene would not impact spacer acquisition,
while deletion of the recG gene would impact new spacer inser-
tion.
A deletion of the recD gene was generated in P. aeruginosa, and
this mutant strain was incubated with DMS3vir in the biofilm
enrichment scheme outlined in Fig. 2. Of note, during the LB
growth step between the two biofilm incubations, the cells carry-
ing the recDmutationwere incubated for 10 h instead of 6 h due to
a slight growth defect caused by the deletion of the recD gene;
otherwise, the biofilm enrichment was performed as described
above. At least 200 colonies were repatched after isolation of the
biofilmpopulation from the second incubation, and of the isolates
that had gained resistance to DMS3vir, 30.1% had gained resis-
tance through spacer acquisition, while the remaining 69.9%were
T4P mutants (Fig. 7), similar to the spacer acquisition frequency
observed for the WT population described above (Fig. 6). To test
if the acquired spacers were primed, the CRISPR arrays of 7recD
isolates with newly acquired spacers were sequenced, resulting in
the characterization of 14 newly acquired spacers. As listed in Ta-
ble S4 in the supplemental material, CR2_sp1 likely primed all 14
newly acquired spacers, supporting the hypothesis that RecD and,
presumably, the RecBCD complex are dispensable for primed ad-
aptation in the type I-F CRISPR-Cas system of P. aeruginosa.
To test the requirement for RecG in primed CRISPR adapta-
tion, a P. aeruginosa strain with a transposon stably inserted into
the recG gene was assayed in the biofilm enrichment assay at the
same counts of bacteria and bacteriophages described above (Fig.
2). Of the resistant mutants isolated from the biofilm population
after the second incubation, 99.6%were T4Pmutants, while 0.4%
FIG 6 DMS3 targets of newly acquired spacers demonstrate a bias. The 83
sequenced spacers acquired by WT P. aeruginosa, when incubated with
DMS3vir in the biofilm enrichment assay, within 6,000 bp of the CRISPR2
spacer 1 (CR2_sp1) target are displayed as a function of both the distance from
the CR2_sp1 target and which DMS3 strand (sense or antisense) that each
targets. The dashed line represents the CR2_sp1 target location, with the x axis
representing the distance from the CR2_sp1 target, divided into segments of
500 bp either upstream or downstream of the CR2_sp1 target. Each bar rep-
resents the number of spacers targeting within that particular 500-bp segment
of DMS3, with blue bars representing targets on the positive-sense DMS3
strand and with the yellow bars representing targets on the negative-sense
DMS3 strand.
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(two isolates) had gained resistance through CRISPR adaptation
(Fig. 7). The CRISPR arrays of these two isolates were sequenced,
and the 4 newly acquired spacers were likely primed by CR2_sp1
(see Table S4 in the supplemental material). To confirm that these
data were not due to any polar effect of the transposon in recG, an
in-frame deletion of recGwas generated and assayed in the biofilm
enrichment assay at the same counts of bacteria and bacterio-
phages described above. Of 479 resistant isolates, 99.6%were T4P
mutants, with only 2 isolates (0.4%) gaining resistance through
spacer acquisition, confirming that while RecG is necessary for
efficient CRISPR adaptation, priming can still occur in a recG
mutant strain, albeit at a greatly reduced rate.
Spacers incorporated using biofilm enrichment are biased
toward CR2_sp1 priming over CR2_sp20 priming due to the
specific location of mismatches between the spacer and the tar-
get. One observation made using the biofilm enrichment assay
was that almost all of the newly incorporated sequenced spacers
were apparently primed by CR2_sp1. The CRISPR2 array of iso-
late 33 listed in Table S3 in the supplemental material contains
three newly acquired spacers which were likely primed by
CR2_sp20 due to the proximity of the spacer targets on DMS3 to
the target of CR2_sp20. This is the only example obtained using
the biofilm enrichment assay of a spacer other thanCR2_sp1 likely
mediating priming, and we hypothesized that deletion of
CR2_sp1 would enrich for alternatively primed spacer acquisi-
tions. A strain in which the first two spacers of CRISPR2 were
deleted (the CR2_sp1,2 strain) was coinoculated with DMS3vir
in the biofilm enrichment assay under the same counts of bacteria
and bacteriophage described above. Interestingly, CRISPR adap-
tation was greatly reduced without CR2_sp1, with only a single
isolate (0.3%) of the resistant biofilm population gaining resis-
tance through spacer acquisition (Fig. 7). This isolate was se-
quenced, and the resulting single acquired spacer appeared to be
primed by CR2_sp20 since the target of the new spacer was only
1.2 kb upstreamof the CR2_sp20DMS3 target. These data suggest
that a large difference in priming efficiency can exist between two
priming spacers in an endogenous type I-F CRISPR-Cas system.
One possibility for the reduced rate of spacer acquisition ob-
served with the CR2_sp1,2 strain is the distance between
CR2_sp20 and the leader sequence of CRISPR2, since it has been
observed in Pyrococcus furiosus that crRNA from the spacers clos-
est to the leader accumulates to a higher level than crRNA from
spacers farther from the leader sequence (33). To test if the lower
ability of CR2_sp20 to prime is related to the distance of
CR2_sp20 to the CRISPR2 leader sequence, a strain was generated
in which the entire CRISPR1 array and CRISPR2 spacers 1 to 19
were deleted (the CR1 CR2_sp1-19 strain; see Fig. S1 in the
supplemental material), resulting in CR2_sp20 being the spacer
closest to the CRISPR2 leader sequence. To confirm that
CR2_sp20 was functional in this strain, a mutant of DMS3vir was
generated in which the CR2_sp20 target contained the correct
PAM (GG) instead of the nonfunctional PAM (AG) normally
present in wild-type DMS3. This A-to-Gmutation is synonymous
and therefore unlikely to affect the ability of the phage to infect P.
aeruginosa. This mutant phage, referred to as DMS3vir-PC (in
reference to PAMcorrected), should therefore not be able to infect
the CR1 CR2_sp1-19 strain (as measured by plaque assay) if
CR2_sp20 is functional due to CRISPR interference. As illustrated
in Fig. S2, DMS3vir-PC could infect CRISPR-deficient P. aerugi-
nosa (the CR strain) but not the CR1 CR2_sp1-19 strain,
confirming that CR2_sp20 was still functional.
The CR1 CR2_sp1-19 strain was assayed in the biofilm en-
richment assay at the same counts of bacteria and bacteriophages
described above. Interestingly, even with CR2_sp20 being proxi-
mal to the leader, the rate of spacer acquisition was still low, with
99% (513 out of 518) of the resistant isolates gaining resistance to
DMS3vir through T4P mutations and only 1% (5 out of 518) of
the isolates gaining resistance to DMS3vir through spacer acqui-
sition (Fig. 7, bar second from the right).
The CRISPR array of isolates of the CR1 CR2_sp1-19 mu-
tant that gained resistance through spacer acquisition was se-
quenced to determine the location on the DMS3 genome from
which the newly acquired spacers were derived. As expected, three
of the isolates had spacers derived from target regions close to the
target of CR2_sp20 (see Table S4 in the supplemental material);
however, all of the spacers in isolate 4 target regions of DMS3 that
were at least 14.5 kb from the target region of CR2_sp20. Interest-
ingly, the region of DMS3 targeted by these new spacers, while far
from the target region of CR2_sp20, was very close (about 1,000
bp) to the target region of CR2_sp1, even though CR2_sp1 was
deleted in this strain, suggesting that the region near the CR2_sp1
target is potentially more amenable to spacer acquisition.
An alternate explanation as towhyCR2_sp1 ismore efficient at
priming thanCR2_sp20 is the difference in sequences that prevent
CRISPR interference. While CR2_sp1 has 5 mismatches between
the spacer and the protospacer, CR2_sp20 instead has only a single
mutation in the PAM. Therefore, to test the hypothesis that
CR2_sp20 would be more efficient at priming if it had sequence
changes at a position similar to that with sequence changes in
CR2_sp1, a version of the CR1 CR2_sp1-19 strain in which
FIG 7 Contributions to new spacer acquisition. RecD is dispensable for
primed spacer acquisition, RecG and CRISPR2 spacer 1 are necessary for effi-
cient primed spacer acquisition, and CRISPR2 spacer 20 is sufficient for
primed spacer acquisition when the mismatches are in positions similar to
those of CRISPR2 spacer 1 in the biofilm enrichment assay. After the second
challenge in the biofilm enrichment assay, the biofilm population of P. aerugi-
nosa (either theWTor the specifiedmutant) coincubatedwith either DMS3vir
(first six columns) or DMS3vir-PC (last column on the right) was plated for
single colonies. At least 200 colonies under each specified condition from at
least two replicates were repatched on LB agar. Isolates that were resistant to
DMS3vir and twitch negative were scored as type IV pilus (T4P) mutants,
while isolates that were resistant to DMS3vir, twitch positive, and demon-
strated spacer acquisition, as determined by PCR of the CRISPR arrays, were
scored as spacer acquisition positive. The type IV pilus mutant and spacer
acquisition-positive isolates from each condition are displayed as a percentage
of the total DMS3vir-resistant population under that condition.
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CR2_sp20 had mismatches at positions identical to the locations
of mismatches in CR2_sp1, referred to as CR1 CR2_sp1-20
sp20-5MM (for 5 mismatches), was constructed and is illustrated
in Fig. S3 in the supplemental material. This strain was assayed in
the biofilm enrichment assay at the same counts of bacteria and
bacteriophages described above, with a key difference being that
DMS3vir-PCwas used instead of DMS3vir.We usedDMS3vir-PC
here because, to be similar to CR2_sp1, CR2_sp20-5MM would
need to target a region of DMS3 with the correct PAM. For the
biofilm enrichment assay, three biological replicates were per-
formed with at least 200 isolates each. Strikingly, unlike the low
rate of CRISPR adaptation observed with the CR1 CR2_sp1-
19 strain (5 out of 518 resistant isolates), with the CR1
CR2_sp1-20  sp20-5MM strain, 424 out of 476 resistant iso-
lates gained resistance through spacer acquisition (89%) (Fig. 7).
Thiswas the highest rate ofCRISPR adaptation in resistant isolates
observed among isolates of any strain, including the wild-type P.
aeruginosa strain.
Overall, these data suggest that certain spacers are much
better at priming than others and that one reason for the vari-
ability is the specific sequences causing mismatches between
the spacer and the protospacer, rather than the location of the
target or the overall sequence of the spacer. Furthermore,
primed adaptation is the predominant (and perhaps only)
mode of spacer acquisition in the P. aeruginosa type I-F CRISPR-
Cas system, as we were unable to detect naive adaptation using the
biofilm enrichment assay.
DISCUSSION
By developing a strategy of enriching for biofilm-grown cells dur-
ing challenge with the lytic bacteriophage DMS3vir, we have re-
duced the frequency of phage receptor mutations dominating the
resistant population. We also developed an assay system that al-
lows robust spacer acquisition through endogenous expression of
the P. aeruginosa type I-F CRISPR system. This assay system al-
lowed us to characterize the genetic requirements of primed
CRISPR adaptation against a lytic bacteriophage and find that the
cas1 gene is required for CRISPR adaptation, the recG gene con-
tributes to efficient primed CRISPR adaptation, and the recD gene
is dispensable for primed CRISPR adaptation. Furthermore, due
to the presence of 3 putative priming spacers against DMS3vir in
the native CRISPR2 array in P. aeruginosa, the contribution of
specific spacers to CRISPR-acquired immunity against DMS3vir
was investigated, and we found a strong bias wherein CR2_sp1 is
efficient in conferring CRISPR-acquired immunity through
primed adaptation. This high efficiency of priming by CR2_sp1 is
not simply due to the proximity of CR2_sp1 to the CRISPR2
leader sequence and is likely the result of the specific sequences
that prevent functional CRISPR interference.
Preventing bacteriophage adsorption is a common strategy
employed by bacteria to gain resistance to lytic bacteriophages and
is analogous to plasmid-based adsorption interference (34), but
mutations that directly affect the function of surface receptors can
come with a fitness cost (35). Accordingly, the goal of the analysis
of the biofilm enrichment system was not simply to investigate
mechanisms of CRISPR adaptation in P. aeruginosa but also to
develop an assay that may provide insight into why the type I-F
CRISPR-Cas system is typically found in a broad range of P.
aeruginosa strains. The advantage to P. aeruginosa cells provided
by CRISPR adaptation when they were grown in a biofilm in the
presence of bacteriophage over CRISPR-deficient P. aeruginosa
cells was significant and reproducible, perhaps suggesting one rea-
son why this system is conserved in microbes.
Similar to what was observed in other studies involving the
native type I-F system of P. aeruginosa, there were many similari-
ties between the spacers incorporated using the biofilm enrich-
ment assay described here and those incorporated using a plasmid
loss-based systemwith the type I-F system of P. atrosepticum pub-
lished previously (27), despite the differences between the two
assay systems. In both systems, during a primed spacer acquisition
event, multiple spacers are incorporated at a higher rate than sin-
gle spacers (75% versus 25%), spacer incorporation is not equal
among CRISPR arrays, and a nearly identical strand bias exists
regarding selected protospacers. Therefore, these observations
likely reflect general characteristics of the type I-F system and are
not associated with the type of target (i.e., plasmid versus lytic
bacteriophage) or the bacterium that encodes the CRISPR system.
The observation that multiple spacers were typically in-
serted during an acquisition event suggests the ability of P.
aeruginosa to rapidly modify its CRISPR loci. This finding is at
odds with the findings of our previous work (19) showing sur-
prisingly conserved spacer arrays across isolates of this microbe
from India and two sites in the United States (Hanover, NH,
and Pittsburgh, PA). It is possible that the rate of acquisition
observed in the lab does not reflect the rates actually occurring
in natural settings, or alternatively, perhaps such newly ac-
quired spacers are easily lost.
The biofilm selection assay was used to test the requirements
for genome stability proteins previously implicated in CRISPR
adaptation. We found that RecD was dispensable for CRISPR
adaptation in P. aeruginosa, which was not surprising, since the
hypothesized role of the RecBCD complex in P. aeruginosa adap-
tation is to generate single-stranded DNA for Cas1 during naive
adaptation and only primed adaptation was observed in the bio-
film selection assay. Intriguingly, we found that priming could still
occur in the absence of RecG, albeit at a greatly reduced rate. The
putative role of RecG in CRISPR adaptation is to relieve the R loops
formedat siteswhere the crRNAribonucleoprotein complexhaspar-
tially bound its target, thereby allowing Cas1 to access the single-
stranded DNA generated by Cas3. Our data support this model but
demonstrate that RecG is not completely required for Cas1 to access
the single-stranded target and incorporate new spacers.
One of the most striking results obtained with the biofilm en-
richment assay was the difference in priming efficiency between
the CR2_sp20 and CR2_sp1 spacers. It has been shown in the E.
coli type I-E CRISPR-Cas system that spacers that match their
protospacer with 100% complementarity but lack a consensus
PAM (such as CR2_sp20) are efficient priming spacers (29), yet
when either CR2_sp1 or all spacers except CR2_sp20 and
CR2_sp21 were deleted, the spacer acquisition frequency was
greatly reduced to levels similar to those observed in the recG
mutant, indicating that CR2_sp20 is a very poor priming spacer,
despite 100% complementarity with a nonconsensus PAM. The
inefficiency of CR2_sp20 at priming is not due to the location of
CR2_sp20 relative to the CRISPR2 leader, since both a leader-
distant CR2_sp20 and a leader-proximal CR2_sp20 had a poor
priming efficiency. Instead, the inefficiency of CR2_sp20 at prim-
ing can be resolved by engineering CR2_sp20 to have the same
mismatch sites as CR2_sp1 between the spacer and the bacterio-
phage target, which results in rates of priming more efficient than
Heussler et al.
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the rate for CR2_sp1. Further research is needed to determine
which of the 5 mismatches are the most important for this phe-
nomenon and why.
Interestingly, none of the newly acquired spacers sequenced
were likely primed by CR2_sp17, suggesting that when escaping
CRISPR interference, a single nucleotide deletion can be more
beneficial to the bacteriophage than a single nucleotide substitu-
tion, since our data indicate that the substitution can be more
easily overcome through CRISPR priming. Avoidance of priming
for a bacteriophage infecting P. aeruginosa is especially important
since no naive adaptation was detected using the biofilm enrich-
ment assay, suggesting that primed adaptation is the dominant
form of CRISPR adaptation in P. aeruginosa type I-F.
Overall, the biofilm enrichment assay described here provides
a system to study endogenous CRISPR adaptation in the P. aerugi-
nosa type I-F system against a lytic bacteriophage and provides a
complementary data set generated by CRISPR studies in which
artificial expression constructs or mutants are used to investigate
the mechanisms of CRISPR adaptation.
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